Anaprazole

Anaprazole
Identifiers
  • 2-[[3-(3-methoxypropoxy)-2-methylphenyl]methylsulfinyl]-6,7-dihydro-1H-furo[2,3-f]benzimidazole
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC21H24N2O4S
Molar mass400.49 g·mol−1
3D model (JSmol)
  • CC1=C(C=CC=C1OCCCOC)CS(=O)C2=NC3=C(N2)C=C4CCOC4=C3
  • InChI=InChI=1S/C21H24N2O4S/c1-14-16(5-3-6-19(14)26-9-4-8-25-2)13-28(24)21-22-17-11-15-7-10-27-20(15)12-18(17)23-21/h3,5-6,11-12H,4,7-10,13H2,1-2H3,(H,22,23)
  • Key:JYSIFLQJDVIWKM-UHFFFAOYSA-N

Anaprazole is a pharmaceutical drug used for the treatment of duodenal ulcers. It is classified as a proton pump inhibitor (PPI).[1] It was approved for use in China in 2023.[2] It is formulated as its sodium salt, anaprazole sodium, in enteric-coated tablets.[2]

References

  1. ^ Wang F, Niu X, Liu F, Ma X, Cheng F, Xu H, et al. (July 2024). "Safety, Tolerability, and Pharmacokinetics of Anaprazole, a Novel Proton Pump Inhibitor, in Healthy Chinese Subjects". Clinical Pharmacology in Drug Development. 13 (7): 782–789. doi:10.1002/cpdd.1405. PMID 38629191.
  2. ^ a b "Anaprazole Sodium Enteric-coated Tablets Approved for Marketing by China NMPA". Chinese National Medical Products Administration. 2023-06-25.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.